Marco Pirazzini Selected Research

Lipids

5/2011

pH-sensitive PEG-based micelles for tumor targeting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Pirazzini Research Topics

Disease

16	Tetanus 04/2022 - 11/2011
13	Botulism 01/2022 - 12/2011
8	Paralysis (Palsy) 01/2021 - 11/2011
2	Muscle Spasticity (Spastic) 11/2021 - 01/2021
2	Wounds and Injuries (Trauma) 01/2021 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2020
1	X-Linked Bulbo-Spinal Atrophy 01/2020
1	Atrophy 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Muscular Atrophy (Muscle Atrophy) 01/2020
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2020
1	Pathologic Processes 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Dystonia (Limb Dystonia) 08/2017
1	Pain (Aches) 01/2017
1	Nervous System Diseases (Neurological Disorders) 12/2015
1	Neoplasms (Cancer) 05/2011

Drug/Important Bio-Agent (IBA)

17	Botulinum Toxins (Botulinum Toxin)IBA 04/2022 - 11/2011
13	NeurotoxinsIBA 04/2022 - 01/2013
6	SNARE Proteins (SNAREs)IBA 01/2022 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 11/2011
3	Metalloproteases (Metalloproteinases)IBA 04/2022 - 01/2021
3	tetanospasmin (tentoxilysin)IBA 11/2021 - 01/2021
3	DisulfidesIBA 11/2019 - 11/2011
2	Peptides (Polypeptides)IBA 04/2022 - 01/2020
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 05/2017
2	ExotoxinsIBA 11/2021 - 11/2019
2	Qa-SNARE Proteins (Syntaxin)IBA 12/2017 - 08/2017
2	incobotulinumtoxinA FDA Link 12/2015 - 08/2013
2	Pharmaceutical PreparationsIBA 12/2015 - 05/2011
2	ThioredoxinsIBA 09/2014 - 01/2013
2	Thioredoxin-Disulfide ReductaseIBA 09/2014 - 01/2013
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 04/2022
1	rimabotulinumtoxinB FDA Link 04/2022
1	AntibodiesIBA 11/2021
1	EpitopesIBA 11/2021
1	Therapeutic UsesIBA 11/2021
1	Monoclonal AntibodiesIBA 11/2021
1	Formaldehyde (Formol)FDA Link 11/2021
1	Immunoglobulins (Immunoglobulin)IBA 11/2021
1	Hazardous Substances (Hazardous Materials)IBA 07/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	polyglutamineIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2020
1	ebselenIBA 11/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	LigandsIBA 01/2019
1	N-Ethylmaleimide-Sensitive Proteins (N-Ethylmaleimide-Sensitive Fusion Protein)IBA 07/2018
1	Botulinum AntitoxinIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 09/2014
1	Type A Botulinum Toxins (Botox)FDA Link 08/2013
1	botulinum toxin type DIBA 05/2013
1	AcidsIBA 05/2011
1	MicellesIBA 05/2011
1	LipidsIBA 05/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2011
1	polyethylene glycol- distearoylphosphatidylethanolamineIBA 05/2011

Therapy/Procedure

5	Therapeutics 11/2021 - 08/2013
1	Muscle Denervation 01/2020